# RGPX (Regenerex Pharma, Inc.) - SEC EDGAR Financial Statements

> Regenerex Pharma, Inc. reported $618K in total assets and a net loss of $3.20M through March 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/RGPX
- Markdown: https://convexityos.com/fundamentals/RGPX.md
- SEC CIK: 0001357878
- Reporting currency: USD
- Latest filing period: September 30, 2025
- Last synced: Nov 21, 2026, 05:18 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001357878&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Mar 31, 2025 |
| Operating Income | FY 2025 | -$2.73M | Operating profit |
| Net Income | FY 2025 | -$3.20M | GAAP bottom line |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2025 | $12K | Total debt: $584K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | $1.8K | $2.6K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | $247K | $1.7K | -- | -- | -- | -- |
| **Gross Profit** | -- | -- | -- | -- | -$245K | $896 | -- | -- | -- | -- |
| Research & Development | $662K | $2.40M | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, General & Admin | $1.16M | $1.07M | -- | -- | $52K | $78K | -- | -- | -- | -- |
| Total Operating Expenses | $1.83M | $3.47M | $96K | $126K | $43K | $78K | $92K | $49K | $2.6K | $25K |
| **Operating Income** | -$1.83M | -$3.47M | -$96K | -$126K | -$43K | -$77K | -$92K | -$49K | -$2.6K | -- |
| **EBITDA** | -$1.82M | -$3.46M | -$90K | -$119K | -$34K | -$63K | -$81K | -$44K | -- | -- |
| Interest Expense | $320K | $81K | $67K | $59K | $43K | $29K | $778 | -- | -- | $3.6K |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$468K |
| Income Tax Expense | -$2.7K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$2.53M | -$3.54M | -$137K | -$196K | -$354K | $112K | -$94K | -$50K | -$2.6K | $860K |
| Basic Shares Outstanding | 278.7M | 277.7M | 277.1M | 183.4M | 127.1M | 127.1M | 127.1M | 137.7M | 156.1M | -- |
| Diluted Shares Outstanding | -- | -- | -- | 183.4M | 127.1M | 127.1M | 127.1M | 137.7M | 156.1M | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $136K | -- | -- | $17K | -- | -- | -- | -- |
| Total Operating Expenses | $787K | $634K | $1.00M | $312K | $258K | $254K | $280K | $239K |
| **Operating Income** | -$787K | -$634K | -$1.00M | -$312K | -$258K | -$254K | -$280K | -$239K |
| **EBITDA** | -$786K | -$633K | -$1.00M | -$311K | -$257K | -$252K | -$278K | -$238K |
| Interest Expense | $23K | $24K | $4.5K | $27K | $266K | $22K | $22K | $20K |
| Income Tax Expense | -$50 | -$113 | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$814K | -$664K | -$1.41M | -$315K | -$530K | -$273K | -$293K | -$264K |
| Basic Shares Outstanding | 281.5M | 281.1M | -- | 278.4M | 278.3M | 278.2M | -- | 277.9M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $653K | $372 | $1.1K | $2.6K | $6.9K | $6.9K | $5.5K | $89K | $1.7K | $1.3K |
| **Cash & Short-Term Investments** | $653K | $372 | $1.1K | $2.6K | $6.9K | $6.9K | $5.5K | $89K | $1.7K | $1.3K |
| Inventory | -- | -- | -- | -- | -- | -- | $247K | -- | -- | -- |
| **Total Current Assets** | $653K | $2.9K | $1.1K | $7.9K | $8.1K | $8.1K | $252K | $98K | $1.7K | -- |
| Property, Plant & Equipment, Net | -- | $6.1K | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | $5.6K | $1.3K | $4.2K | $7.4K | $2.4K | $2.4K | $7.0K | $8.0K | $13K | $2.5K |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | $2.5K |
| **Total Non-Current Assets** | $610K | $764K | $5.4K | $7.4K | $2.4K | $2.4K | $7.0K | $8.0K | $13K | -- |
| **Total Assets** | $1.26M | $767K | $6.5K | $15K | $10K | $10K | $259K | $106K | $15K | $3.8K |
| Accounts Payable | $198K | $117K | $75K | $63K | $48K | $48K | $51K | $38K | $38K | $37K |
| **Total Current Liabilities** | $4.92M | $3.84M | $777K | $660K | $621K | $621K | $519K | $405K | $336K | -- |
| Long-Term Debt | -- | $184K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $496K | $985K | $353K | $340K | $224K | $224K | $222K | $70K | $0 | -- |
| **Total Liabilities** | $5.42M | $4.83M | $1.13M | $1.00M | $845K | $845K | $740K | $475K | $336K | $799K |
| **Total Debt (incl. Leases)** | $678K | $994K | -- | -- | -- | -- | -- | -- | -- | -- |
| Common Stock | $281K | $278K | $277K | $277K | $127K | $127K | $127K | $127K | $127K | $156K |
| Retained Earnings | -$8.14M | -$5.62M | -$2.07M | -$1.93M | -$1.74M | -$1.74M | -$1.39M | -$1.27M | -$1.18M | -$106K |
| **Total Stockholders' Equity** | -$4.16M | -$4.06M | -$1.12M | -$986K | -$835K | -$835K | -$481K | -$370K | -$321K | -$795K |
| Total Equity | -$4.16M | -$4.06M | -$1.12M | -$986K | -$835K | -$835K | -$481K | -$370K | -$321K | -$795K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $12K | $172K | $653K | $338 | $294 | -- | $372 | $7.9K |
| **Cash & Short-Term Investments** | $12K | $172K | $653K | $338 | $294 | -- | $372 | $7.9K |
| **Total Current Assets** | $48K | $193K | $653K | $988 | $1.8K | $2.4K | $2.9K | $9.3K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $5.2K | -- | $6.1K | -- |
| Intangible Assets | -- | $4.3K | $5.6K | -- | $208 | $614 | $1.3K | $2.0K |
| **Total Non-Current Assets** | $569K | $571K | $610K | $646K | $631K | $727K | $764K | $843K |
| **Total Assets** | $618K | $763K | $1.26M | $647K | $633K | $729K | $767K | $852K |
| Accounts Payable | $219K | $171K | $198K | $185K | $155K | $161K | $117K | $79K |
| **Total Current Liabilities** | $4.92M | $4.85M | $4.92M | $5.16M | $4.85M | $4.41M | $3.84M | $3.56M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | $184K | -- |
| **Total Non-Current Liabilities** | $393K | $459K | $496K | $541K | $540K | $629K | $985K | $1.17M |
| **Total Liabilities** | $5.32M | $5.31M | $5.42M | $5.70M | $5.39M | $5.04M | $4.83M | $4.73M |
| **Total Debt (incl. Leases)** | $584K | $627K | $678K | $718K | $706K | $803K | $994K | $876K |
| Common Stock | $282K | $281K | $281K | $278K | $278K | $278K | $278K | $278K |
| Retained Earnings | -$9.62M | -$8.81M | -$8.14M | -$6.73M | -$6.42M | -$5.89M | -$5.62M | -$5.32M |
| **Total Stockholders' Equity** | -$4.70M | -$4.55M | -$4.16M | -$5.05M | -$4.76M | -$4.31M | -$4.06M | -$3.88M |
| Total Equity | -$4.70M | -$4.55M | -$4.16M | -$5.05M | -$4.76M | -$4.31M | -$4.06M | -$3.88M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.53M | -$3.54M | -$137K | -$196K | $354K | $112K | $94K | $50K | $2.6K | $860K |
| Depreciation & Amortization | $4.4K | $7.2K | $6.6K | $7.1K | $9.3K | $14K | $11K | $5.3K | -- | -- |
| Stock-Based Compensation | $133K | $212K | -- | $45K | -- | -- | $45K | $10K | -- | -- |
| Change in Inventory | -- | -- | -- | -- | -$1.1K | $247K | -- | -- | -- | -- |
| Change in Payables | $188K | $160K | $44K | -- | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$1.63M | -$458K | -$76K | -$70K | -$63K | -$291K | $47K | $36K | $2.6K | -$72K |
| **Investing Cash Flow** | -$1.2K | -$6.3K | -$1.4K | -$8.6K | -- | -$6.0K | -- | -$16K | -- | -- |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -- | -- | $40K |
| **Financing Cash Flow** | $2.28M | $463K | $76K | $74K | $64K | $214K | $134K | $54K | $2.6K | $73K |
| **Net Change in Cash** | $653K | -$763 | -$1.5K | -$4.3K | $1.4K | -$83K | $87K | $1.7K | -- | $7.8K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$814K | -$664K | -$1.41M | -$315K | -$530K | -$273K | -$293K | -$264K |
| Depreciation & Amortization | $1.2K | $1.3K | $426 | $851 | $1.2K | $1.9K | $1.9K | $1.9K |
| Stock-Based Compensation | $178K | $257K | $58K | $18K | $36K | $21K | $57K | $21K |
| Change in Payables | $47K | -$26K | $67K | $51K | $6.8K | $63K | $58K | $9.1K |
| **Operating Cash Flow** | -$519K | -$478K | -$1.28M | -$159K | -$127K | -$55K | -$64K | -$100K |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Financing Cash Flow** | $398K | -$2.7K | $1.94M | $159K | $127K | $55K | $57K | $102K |
| **Net Change in Cash** | -$161K | -$481K | $653K | $44 | $294 | -$372 | -$7.5K | $1.8K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -13798.1% | 34.4% | -- | -- | -- | -- |
| **Operating Margin** | -- | -- | -- | -- | -2445.7% | -2952.6% | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -- | -- | -- | -19929.7% | 4278.7% | -- | -- | -- | -- |
| Return on Assets (ROA) | -200.0% | -462.2% | -2100.2% | -1276.5% | -3378.7% | 43.1% | -88.6% | -329.6% | -- | 22514.5% |
| Current Ratio | 0.13x | 0.00x | 0.00x | 0.01x | 0.01x | 0.49x | 0.24x | 0.01x | -- | -- |
| Quick Ratio | 0.13x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.22x | 0.01x | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -31.9% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -27434.5% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -417.0% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -718.8% | +30.3% | +1303.9% | -- | -- |
| 5Y Net Income / Share Growth | -1132.8% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -518.4% | -382.3% | -200.0% | -217.9% | -214.7% | -498.0% | -462.2% | -386.9% |
| Current Ratio | 0.01x | 0.04x | 0.13x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Quick Ratio | 0.00x | 0.04x | 0.13x | 0.00x | 0.00x | -- | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
